Effect of Pentoxifylline on diabetic neuropathy in patients with type 2 diabetes
Phase 3
- Conditions
- type 2 diabetes.Non-insulin-dependent diabetes mellitus
- Registration Number
- IRCT2016051827965N1
- Lead Sponsor
- Deputy for Research,Qom University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 70
Inclusion Criteria
type 2 diabetes over a year;age group40-75;Distal polyneuropathy resolutions based on questionnaires Michigan;HBA1C8% -10%
Exclusion criteria:Kidney,liver,and heart failure based on the tests, history and physical exam;High blood pressure more than 160 mm Hg and advanced diabetic Retinopathy;The recent use of drugs for neuropathy {gabapentin , nortriptyline};Fever;Pergnancy and lactation;History of amputation
Exclusion Criteria
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method FBS. Timepoint: pre and early post-operation. Method of measurement: Based on Labratory.;HBA1C. Timepoint: pre and early post-operation. Method of measurement: Based on Labratory.
- Secondary Outcome Measures
Name Time Method Distal polyneuropathy. Timepoint: Before and 4 months after the intervention. Method of measurement: Michigan Questionnaire A.